Hysterectomy and myomectomy by laparotomy

Area of Science:

• Gynecology
• Surgical Oncology
• Reproductive Medicine

Background:

• Uterine fibroids are common benign tumors affecting women of reproductive age.
• Symptomatic fibroids significantly impact quality of life and reproductive health.
• Surgical management options include hysterectomy and myomectomy.

Purpose of the Study:

• To review the indications and surgical approaches for uterine fibroids.
• To evaluate the outcomes and risks associated with hysterectomy and myomectomy.
• To discuss the role of GnRH analogues in fibroid management.

Main Methods:

• Literature review of surgical treatments for uterine fibroids.
• Analysis of indications for hysterectomy versus myomectomy.
• Evaluation of surgical approaches (laparotomy, abdominal hysterectomy, vaginal hysterectomy) based on uterine size.
• Assessment of GnRH analogue use for fibroid shrinkage.

Main Results:

• Hysterectomy is definitive for symptomatic fibroids; size alone is not an indication.
• Myomectomy preserves uterine function with encouraging pregnancy prospects but risk of recurrence.
• Laparotomy is preferred for large fibroids; vaginal hysterectomy suits smaller uteri (12-14 week size).
• Morbidity of abdominal procedures may increase with very large uteri.
• GnRH analogues may aid vaginal hysterectomy or pre-operative fibroid reduction, but cost-effectiveness for abdominal procedures is unproven.

Conclusions:

• Symptomatic uterine fibroids require tailored surgical treatment.
• Hysterectomy and myomectomy offer distinct benefits and risks.
• Surgical approach selection depends on fibroid size and patient's reproductive desires.
• GnRH analogues show potential utility in specific surgical contexts for uterine fibroids.